Image-guided tumorablation: Standardization ofterminology and reporting criteria-A 10-year update

Journal of Vascular and Interventional Radiology

Volumn 25, Issue 11, 2014, Pages 1691-1705.e4

  Ahmed, Muneeb ^a   Solbiati, Luigi ^b   Brace, Christopher L ^c   Breen, David J ^d   Callstrom, Matthew R ^e   Charboneau, J William ^e   Chen, Min Hua ^f   Choi, Byung Ihn ^g   De Baère, Thierry ^h   Dodd, Gerald D ⁱ   Dupuy, Damian E ^j   Gervais, Debra A ^k   Gianfelice, David ^l   Gillams, Alice R ^m   Lee, Fred T ⁿ   Leen, Edward ^o   Lencioni, Riccardo ^p   Littrup, Peter J ^q   Livraghi, Tito ^g   Lu, David S ^r   Mcgahan, John P ^s   Meloni, Maria Franca ^t   Nikolic, Boris ^u   Pereira, Philippe L ^v   Liang, Ping ^w   Rhim, Hyunchul ^x   Rose, Steven C ^y   Salem, Riad ^z   Sofocleous, Constantinos T ^aa   Solomon, Stephen B ^aa   Soulen, Michael C ^ab   Tanaka, Masatoshi ^ac   Vogl, Thomas J ^ad   Wood, Bradford J ^ae   Goldberg, S Nahum ^af   more..

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b Ospedale Generale   (Italy)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

^d UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

^e MAYO CLINIC   (United States)

^f PEKING UNIVERSITY   (China)

^g Seoul NationalUniversityHospital ^*  (Italy)

^h INSTITUT GUSTAVE ROUSSY   (France)

ⁱ UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^j RHODE ISLAND HOSPITAL   (United States)

^k MASSACHUSETTS GENERAL HOSPITAL   (United States)

^l UNIVERSITY HEALTH NETWORK   (Canada)

^m London Clinic Cancer Centre   (United Kingdom)

ⁿ University of Wisconsin Health   (United States)

^o GLASGOW ROYAL INFIRMARY   (United Kingdom)

^p UNIVERSITY OF PISA   (Italy)

^q WAYNE STATE UNIVERSITY   (United States)

^r UNIVERSITY OF CALIFORNIA   (United States)

^s Ellison Ambulatory Care Center   (United States)

^t VALDUCE HOSPITAL   (Italy)

^u ALBERT EINSTEIN MEDICAL CENTER   (United States)

^v UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^w CHINESE PLA GENERAL HOSPITAL   (China)

^x Sungkyunkwan University School of Medicine   (South Korea)

^y UNIVERSITY OF CALIFORNIA   (United States)

^z NORTHWESTERN UNIVERSITY   (United States)

^aa MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^ab HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^ac Yokokura Hospital   (Japan)

^ad UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^ae NATIONAL INSTITUTES OF HEALTH   (United States)

^af HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID; ALCOHOL;

ABLATION THERAPY; ACCURACY; ADJUVANT THERAPY; AIRFLOW; ARTICLE; BLOOD FLOW; CANCER THERAPY; CELL DEATH; CHEMOEMBOLIZATION; COMPUTER ASSISTED TOMOGRAPHY; CRYOABLATION; ELECTROPORATION; FOLLOW UP; HUMAN; LASER SURGERY; MICROWAVE RADIATION; MICROWAVE THERAPY; NOMENCLATURE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RADIOFREQUENCY; RADIOFREQUENCY ABLATION; STANDARDIZATION; TREATMENT RESPONSE; TUMOR ABLATION; ULTRASOUND THERAPY; CATHETER ABLATION; CONSENSUS DEVELOPMENT; INTERVENTIONAL RADIOLOGY; NEOPLASMS; PROCEDURES;

CATHETER ABLATION; HUMANS; NEOPLASMS; RADIOLOGY, INTERVENTIONAL;

EID: 84925365673     PISSN: 10510443     EISSN: 15357732     Source Type: Journal    
DOI: 10.1016/j.jvir.2014.08.027     Document Type: Article

References (99)

1. Goldberg SN, Charboneau JW, Dodd GD III, et al. Image-guided tumor ablation: proposal for standardization of terms and reporting criteria. Radiology 2003; 228:335-345.
2. Froeling V, Meckelburg K, Schreiter NF, et al. Outcome of uterine artery embolization versus MR-guided high-intensity focused ultrasound treatment for uterine fibroids: long-term results. Eur J Radiol 2013; 82:2265-2269.
3. Groeschl RT, Pilgrim CH, Hanna EM, et al. Microwave ablation for hepatic malignancies: A multiinstitutional analysis. Ann Surg 2014; 259:1195-1200.
4. Narayanan G, Hosein PJ, Arora G, et al. Percutaneous irreversible electroporation for downstaging and control of unresectable pancreatic adenocarcinoma. J Vasc Interv Radiol 2012; 23:1613-1621.
5. Kim YS, Lim HK, Rhim H, et al. Ten-year outcomes of percutaneous radiofrequency ablation as first-line therapy of early hepatocellular carcinoma: Analysis of prognostic factors. J Hepatol 2013; 58:89-97.
6. Psutka SP, Feldman AS, McDougal WS, McGovern FJ, Mueller P, Gervais DA. Long-term oncologic outcomes after radiofrequency ablation for T1 renal cell carcinoma. Eur Urol 2013; 63:486-492.
7. Solbiati L, Ahmed M, Cova L, lerace T, Brioschi M, Goldberg SN. Small liver colorectal metastases treated with percutaneous radiofrequency ablation: local response rate and long-term survival with up to 10-year follow-up. Radiology 2012; 265:958-968.
8. Peng ZW, Zhang YJ, Chen MS, et al. Radiofrequency ablation with or without transcatheter arterial chemoembolization in the treatment of hepatocellular carcinoma: A prospective randomized trial. J Clin Oncol 2013; 31:426-432.
9. Ruers T, Punt C, Van Coevorden F, et al. Radiofrequency ablation combined with systemic treatment versus systemic treatment alone in patients with non-resectable colorectal liver metastases: A randomized EORTC lntergroup phase II study (EORTC 40004). Ann Oncol 2012; 23:2619-2626.
10. Ahmed M, Brace CL, Lee FT Jr, Goldberg SN. Principles of and advances in percutaneous ablation. Radiology 2011; 258:351-369.
11. Dodd GD III, Soulen MC, Kane RA, et al. Minimally invasive treatment of malignant hepatic tumors: At the threshold of a major breakthrough. RadioGraphics 2000; 20:9-27.
12. Goldberg SN, Gazelle GS, Mueller PR. Thermal ablation therapy for focal malignancy: A unified approach to underlying principles, techniques, and diagnostic imaging guidance. AJR Am J Roentgenol 2000; 174:323-331.
13. Herbold T, Wahba R, Bangard C, Demir M, Drebber U, Stippel DL. The laparoscopic approach for radiofrequency ablation of hepatocellular carcinoma: indication, technique and results. Langenbecks Arch Surg 2013; 398:47-53.
14. Vavra P, Dostalik J, Zacharoulis D, Khorsandi SE, Khan SA, Habib NA. Endoscopic radiofrequency ablation in colorectal cancer: initial clinical results of a new bipolar radiofrequency ablation device. Dis Colon Rectum 2009; 52:355-358.
15. Golberg A, Yarmush ML. Nonthermal irreversible electroporation: fundamentals, applications, and challenges. IEEE Trans Biomed Eng 2013; 60:707-714.
16. Faroja M, Ahmed M, Appelbaum L, et al. Irreversible electroporation ablation: is all the damage nonthermal? Radiology 2013; 266:462-470.
17. Cressman EN, Jahangir DA. Dual mode single agent thermochemical ablation by simultaneous release of heat energy and acid: hydrolysis of electrophiles. Int J Hyperthermia 2013; 29:71-78.
18. Fartoux L, Arrive L, Andreani T, et al. Treatment of small hepatocellular carcinoma with acetic acid percutaneous injection. Gastroenterol Clin Biol 2005; 29:1213-1219.
19. Livraghi T, Giorgio A, Marin G, et al. Hepatocellular carcinoma and cirrhosis in 746 patients: long-term results of percutaneous ethanol injection. Radiology 1995; 197:101-108.
20. Yan K, Chen MH, Yang W, et al. Radiofrequency ablation of hepatocellular carcinoma: long-term outcome and prognostic factors. Eur J Radiol 2008; 67:336-347.
21. Brace CL. Microwave tissue ablation: biophysics, technology, and applications. Crit Rev Biomed Eng 2010; 38:65-78.
22. Sommer CM, Lemm G, Hohenstein E, et al. Bipolar versus multipolar radio- frequency (RF) ablation for the treatment of renal cell carcinoma: differences in technical and clinical parameters. Int J Hyperthermia 2013; 29:21-29.
23. Vogl TJ, Naguib NN, Gruber-Rouh T, Koitka K, Lehnert T, Nour-Eldin NE. Microwave ablation therapy: clinical utility in treatment of pulmonary metastases. Radiology 2011; 261:643-651.
24. Merckel LG, Bartels LW, Kohler MO, et al. MR-guided high-intensity focused ultrasound ablation of breast cancer with a dedicated breast platform. Cardiovasc Intervent Radiol 2013; 36:292-301.
25. Haar GT, Coussios C. High intensity focused ultrasound: physical principles and devices. Int J Hyperthermia 2007; 23:89-104.
26. Lafon C, Melodelima D, Salomir R, Chapelon JY. Interstitial devices for minimally invasive thermal ablation by high-intensity ultrasound. Int J Hyperthermia 2007; 23:153-163.
27. Rosenberg C, Puls R, Hegenscheid K, et al. Laser ablation of metastatic lesions of the lung: long-term outcome. AJR Am J Roentgenol 2009; 192: 785-792.
28. Vogl TJ, Dommermuth A, Heinle B, et al. Colorectal cancer liver metastases: long-term survival and progression-free survival after thermal ablation using magnetic resonance- guided laser-induced interstitial thermotherapy in 594 patients: Analysis of prognostic factors. Invest Radiol 2014; 49:48-56.
29. Callstrom MR, Dupuy DE, Solomon SB, et al. Percutaneous image- guided cryoablation of painful metastases involving bone: multicenter trial. Cancer 2013; 119:1033-1041.
30. Georgiades CS, Hong K, Bizzell C, Geschwind JF, Rodriguez R. Safety and efficacy of CT-guided percutaneous cryoablation for renal cell carcinoma. J Vasc Interv Radiol 2008; 19:1302-1310.
31. Rubinsky B, Lee CY, Bastacky J, Onik G. The process of freezing and the mechanism of damage during hepatic cryosurgery. Cryobiology 1990; 27:85-97.
32. Ben-David E, Appelbaum L, Sosna J, Nissenbaum I, Goldberg SN. Characterization of irreversible electroporation ablation in in vivo porcine liver. AJR Am J Roentgenol 2012; 198:W62-W68.
33. Lencioni R, Crocetti L, Cioni D, et al. Single-session percutaneous ethanol ablation of early-stage hepatocellular carcinoma with a multi- pronged injection needle: results of a pilot clinical study. J Vasc Interv Radiol 2010; 21:1533-1538.
34. Goldberg SN, Gazelle GS, Dawson SL, Rittman WJ, Mueller PR, Rosenthal DI. Tissue ablation with radiofrequency: effect of probe size, gauge, duration, and temperature on lesion volume. Acad Radiol 1995; 2:399-404.
35. Stafford RJ, Fuentes D, Elliott AA, Weinberg JS, Ahrar K. Laser-induced thermal therapy for tumor ablation. Crit Rev Biomed Eng 2010; 38:79-100.
36. Cabassa P, Donato F, Simeone F, Grazioli L, Romanini L. Radiofrequency ablation of hepatocellular carcinoma: long-term experience with expandable needle electrodes. AJR Am J Roentgenol 2006; 186:S316-S321.
37. Shock SA, Meredith K, Warner TF, et al. Microwave ablation with loop antenna: in vivo porcine liver model. Radiology 2004; 231:143-149.
38. Goldberg SN, Solbiati L, Hahn PF, et al. Large-volume tissue ablation with radio frequency by using a clustered, internally cooled electrode technique: laboratory and clinical experience in liver metastases. Radiology 1998; 209:371-379.
39. Lubner MG, Hinshaw JL, Andreano A, Sampson L, Lee FT Jr, Brace CL. High-powered microwave ablation with a small-gauge, gas- cooled antenna: initial ex vivo and in vivo results. J Vasc Interv Radiol 2012; 23:405-411.
40. Kim SK, Gu MS, Hong HP, Choi D, Chae SW. CT findings after radiofrequency ablation in rabbit livers: comparison of internally cooled electrodes, perfusion electrodes, and internally cooled perfusion electrodes. J Vasc Interv Radiol 2007; 18:1417-1427.
41. Cua IH, Lin CC, Lin CJ, et al. Treatment of hepatocellular carcinoma using internally cooled electrodes: A prospective comparison of modified automated vs. manual pulsed radiofrequency algorithms. Oncology 2007; 72:76-82.
42. Park MJ, Kim YS, Rhim H, Lim HK, Lee MW, Choi D. A comparison of US- guided percutaneous radiofrequency ablation of medium-sized hepatocellular carcinoma with a cluster electrode or a single electrode with a multiple overlapping ablation technique. J Vasc Interv Radiol 2011; 22:771-779.
43. Chen MH, Yang W, Yan K, et al. Large liver tumors: protocol for radiofrequency ablation and its clinical application in 110 patients- mathematic model, overlapping mode, and electrode placement process. Radiology 2004; 232:260-271.
44. Dodd GD III, Frank MS, Aribandi M, Chopra S, Chintapalli KN. Radio- frequency thermal ablation: computer analysis of the size of the thermal injury created by overlapping ablations. AJR Am J Roentgenol 2001; 177:777-782.
45. Laeseke PF, Sampson LA, Haemmerich D, et al. Multiple-electrode radiofrequency ablation creates confluent areas of necrosis: in vivo porcine liver results. Radiology 2006; 241:116-124.
46. Brace CL, Sampson LA, Hinshaw JL, Sandhu N, Lee FT Jr. Radio- frequency ablation: Simultaneous application of multiple electrodes via switching creates larger, more confluent ablations than sequential application in a large animal model. J Vasc Interv Radiol 2009; 20:118-124.
47. Brace CL, Laeseke PF, Sampson LA, Frey TM, van der Weide DW, Lee FT Jr. Microwave ablation with multiple simultaneously powered small-gauge triaxial antennas: results from an in vivo swine liver model. Radiology 2007; 244:151-156.
48. Brace CL. Radiofrequency and microwave ablation of the liver, lung, kidney, and bone: what are the differences? Curr Probl Diagn Radiol 2009; 38:135-143.
49. Dodd GD III, Dodd NA, Lanctot AC, Glueck DA. Effect of variation of portal venous blood flow on radiofrequency and microwave ablations in a blood- perfused bovine liver model. Radiology 2013; 267:129-136.
50. Lu DS, Raman SS, Vodopich DJ, Wang M, Sayre J, Lassman C. Effect of vessel size on creation of hepatic radiofrequency lesions in pigs: Assessment of the "heat sink" effect. AJR Am J Roentgenol 2002; 178:47-51.
51. Oshima F, Yamakado K, Akeboshi M, et al. Lung radiofrequency ablation with and without bronchial occlusion: experimental study in porcine lungs. J Vasc Interv Radiol 2004; 15:1451-1456.
52. Livraghi T, Goldberg SN, Lazzaroni S, et al. Hepatocellular carcinoma: radio-frequency ablation of medium and large lesions. Radiology 2000; 214:761-768.
53. Goldberg SN, Hahn PF, Tanabe KK, et al. Percutaneous radiofrequency tissue ablation: does perfusion-mediated tissue cooling limit coagulation necrosis? J Vasc Interv Radiol 1998; 9:101-111.
54. Ginat DT, Saad WE. Bowel displacement and protection techniques during percutaneous renal tumor thermal ablation. Tech Vasc Interv Radiol 2010; 13:66-74.
55. Callstrom MR, York JD, Gaba RC, et al. Research reporting standards for image-guided ablation of bone and soft tissue tumors. J Vasc Interv Radiol 2009; 20:1527-1540.
56. Pelayo-Alvarez M, Perez-Hoyos S, Agra-Varela Y. Reliability and concurrent validity of the Palliative Outcome Scale, the Rotterdam Symptom Checklist, and the Brief Pain Inventory. J Palliat Med 2013; 16:867-874.
57. Kaufman CS, Bachman B, Littrup PJ, et al. Office-based ultrasound-guided cryoablation of breast fibroadenomas. Am J Surg 2002; 184:394-400.
58. Mendiratta-Lala M, Brennan DD, Brook OR, et al. Efficacy of radio- frequency ablation in the treatment of small functional adrenal neoplasms. Radiology 2011; 258:308-316.
59. Rosenthal DI, Hornicek FJ, Torriani M, Gebhardt MC, Mankin HJ. Osteoid osteoma: percutaneous treatment with radiofrequency energy. Radiology 2003; 229:171-175.
60. Ahmed M, Moussa M, Goldberg SN. Synergy in cancer treatment between liposomal chemotherapeutics and thermal ablation. Chem Phys Lipids 2012; 165:424-437.
61. Spalding AC, Lawrence TS. New and emerging radiosensitizers and radioprotectors. Cancer Invest 2006; 24:444-456.
62. Grieco CA, Simon CJ, Mayo-Smith WW, DiPetrillo TA, Ready NE, Dupuy DE. Percutaneous image-guided thermal ablation and radiation therapy: outcomes of combined treatment for 41 patients with inoperable stage I/II non-small-cell lung cancer. J Vasc Interv Radiol 2006; 17:1117-1124.
63. Hamamoto S, Okuma T, Yamamoto A, et al. Radiofrequency ablation and immunostimulant OK-432: combination therapy enhances systemic antitumor immunity for treatment of VX2 lung tumors in rabbits. Radiology 2013; 267:405-413.
64. Solomon SB, Silverman SG. Imaging in interventional oncology. Radiology 2010; 257:624-640.
65. Claudon M, Dietrich CF, Choi BI, et al. Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) in the liver-update 2012: A WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS. Ultraschall Med 2013; 34:11-29.
66. Chen MH, Yang W, Yan K, et al. The role of contrast-enhanced ultrasound in planning treatment protocols for hepatocellular carcinoma before radiofrequency ablation. Clin Radiol 2007; 62:752-760.
67. Clasen S, Pereira PL. Magnetic resonance guidance for radiofrequency ablation of liver tumors. J Magn Reson Imaging 2008; 27:421-433.
68. Abi-Jaoudeh N, Kruecker J, Kadoury S, et al. Multimodality image fusion-guided procedures: Technique, accuracy, and applications. Cardio- vasc Intervent Radiol 2012; 35:986-998.
69. Wood BJ, Kruecker J, Abi-Jaoudeh N, et al. Navigation systems for ablation. J Vasc Interv Radiol 2010; 21:S257-S263.
70. Wang X, Sofocleous CT, Erinjeri JP, et al. Margin size is an independent predictor of local tumor progression after ablation of colon cancer liver metastases. Cardiovasc Intervent Radiol 2013; 36:166-175.
71. Rendon RA, Kachura JR, Sweet JM, et al. The uncertainty of radio frequency treatment of renal cell carcinoma: findings at immediate and delayed nephrectomy. J Urol 2002; 167:1587-1592.
72. Sofocleous CT, Nascimento RG, Petrovic LM, et al. Histopathologic and immunohistochemical features of tissue adherent to multitined electrodes after RF ablation of liver malignancies can help predict local tumor progression: initial results. Radiology 2008; 249:364-374.
73. Goldberg SN, Gazelle GS, Compton CC, Mueller PR, Tanabe KK. Treatment of intrahepatic malignancy with radiofrequency ablation: radiologic- pathologic correlation. Cancer 2000; 88:2452-2463.
74. Coad JE, Kosari K, Humar A, Sielaff TD. Radiofrequency ablation causes 'thermal fixation' of hepatocellular carcinoma: A post-liver transplant histopathologic study. Clin Transplant 2003; 17:377-384.
75. Motoyoshi A, Noguchi M, Earashi M, Zen Y, Fujii H. Histopathological and immunohistochemical evaluations of breast cancer treated with radiofrequency ablation. J Surg Oncol 2010; 102:385-391.
76. Thomsen S. Pathologic analysis of photothermal and photomechanical effects of laser-tissue interactions. Photochem Photobiol 1991; 53:825-835.
77. Lee EW, Loh CT, Kee ST. Imaging guided percutaneous irreversible electroporation: ultrasound and immunohistological correlation. Technol Cancer Res Treat 2007; 6:287-294.
78. Sainani NI, Gervais DA, Mueller PR, Arellano RS. Imaging after percutaneous radiofrequency ablation of hepatic tumors. I. Normal findings. AJR Am J Roentgenol 2013; 200:184-193.
79. Tsivian M, Kim CY, Caso JR, Rosenberg MD, Nelson RC, Polascik TJ. Contrast enhancement on computed tomography after renal cryoablation: An evidence of treatment failure? J Endourol 2012; 26:330-335.
80. Kim YS, Lee WJ, Rhim H, Lim HK, Choi D, Lee JY. The minimal ablative margin of radiofrequency ablation of hepatocellular carcinoma (. 2 and, 5 cm) needed to prevent local tumor progression: 3D quantitative assessment using CT image fusion. AJR Am J Roentgenol 2010; 195:758-765.
81. Levinson AW, Su LM, Agarwal D, et al. Long-term oncological and overall outcomes of percutaneous radio frequency ablation in high risk surgical patients with a solitary small renal mass. J Urol 2008; 180: 499-504, (discussion 504).
82. Kawamoto S, Solomon SB, Bluemke DA, Fishman EK. Computed tomography and magnetic resonance imaging appearance of renal neoplasms after radiofrequency ablation and cryoablation. Semin Ultrasound CT MR 2009; 30:67-77.
83. yer RS, Timm BA, Mitsumori LM, Kolokythas O. Image fusion as a new postprocessing method to evaluate the radiofrequency ablation zone after treatment of malignant liver tumors. J Comput Assist Tomogr 2010; 34:226-228.
84. Brace CL, Diaz TA, Hinshaw JL, Lee FT Jr. Tissue contraction caused by radiofrequency and microwave ablation: A laboratory study in liver and lung. J Vasc Interv Radiol 2010; 21:1280-1286.
85. Georgiades C, Rodriguez R, Azene E, et al. Determination of the nonlethal margin inside the visible "ice-ball" during percutaneous cryoablation of renal tissue. Cardiovasc Intervent Radiol 2013; 36:783-790.
86. Forner A, Ayuso C, Varela M, et al. Evaluation of tumor response after locoregional therapies in hepatocellular carcinoma: Are response evaluation criteria in solid tumors reliable? Cancer 2009; 115:616-623.
87. Laeseke PF, Lee FT Jr, Sampson LA, van der Weide DW, Brace CL. Microwave ablation versus radiofrequency ablation in the kidney: high- power triaxial antennas create larger ablation zones than similarly sized internally cooled electrodes. J Vasc Interv Radiol 2009; 20:1224-1229.
88. Sacks D, McClenny TE, Cardella JF, Lewis CA. Society of Interventional Radiology clinical practice guidelines. J Vasc Interv Radiol 2003; 14: S199-S202.
89. Clavien PA, Barkun J, de Oliveira ML, et al. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg 2009; 250:187-196.
90. Common Terminology Criteria for Adverse Events (CTCAE) v4.0. National Cancer Institute. http://evs.nci.nih.gov/ftp1/CTCAE/CTCAE-4.03-2010-06-14-QuickReference-5x7.pdf. Accessed May 26, 2014.
91. Wang YB, Chen MH, Yan K, Yang W, Dai Y, Yin SS. Quality of life after radiofrequency ablation combined with transcatheter arterial chemo- embolization for hepatocellular carcinoma: comparison with transcatheter arterial chemoembolization alone. Qual Life Res 2007; 16:389-397.
92. Lencioni R, Llovet JM. Modified RECIST (mRECIST) assessment for hepatocellular carcinoma. Semin Liver Dis 2010; 30:52-60.
93. Steele G Jr, Bleday R, Mayer RJ, Lindblad A, Petrelli N, Weaver D. A prospective evaluation of hepatic resection for colorectal carcinoma metastases to the liver: Gastroin testinal Tumor Study Group Protocol 6584. J Clin Oncol 1991; 9:1105-1112.
94. Mulier S, Ni Y, Jamart J, Michel L, Marchal G, Ruers T. Radiofrequency ablation versus resection for resectable colorectal liver metastases: Time for a randomized trial? Ann Surg Oncol 2008; 15:144-157.
95. Sacks D, Marinelli DL, Martin LG, Spies JB, Society of Interventional Radiology Technology Assessment Committee. General principles for evaluation of new interventional technologies and devices. J Vasc Interv Radiol 2003; 14:S391-S394.
96. Grunkemeier GL, Starr A. Alternatives to randomization in surgical studies. J Heart Valve Dis 1992; 1:142-151.
97. Alexander ES, Machan JT, Ng T, Breen LD, DiPetrillo TA, Dupuy DE. Cost and effectiveness of radiofrequency ablation versus limited surgical resection for stage I non-small-cell lung cancer in elderly patients: is less more? J Vasc Interv Radiol 2013; 24:476-482.
98. Shetty SK, Rosen MP, Raptopoulos V, Goldberg SN. Cost-effectiveness of percutaneous radiofrequency ablation for malignant hepatic neoplasms. J Vasc Interv Radiol 2001; 12:823-833.
99. Guyatt GH, Feeny DH, Patrick DL. Measuring health-related quality of life. Ann Intern Med 1993; 118:622-629.